Tao et al. [34] demonstrated that a low density of FoxP3+ TILs indicated a better response to induction chemoradiation and better survival in locally advanced NSCLC, although the difference was not statistically significant, suggesting that FoxP3+ TILs might be a target for adjunct immunotherapy. Here, FOXP3 is linked to non-small cell lung carcinoma.